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Editorial
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Dr. Kubota and colleagues (1) have applied a new infrared
coagulator to assist surgical treatment of infective
endocarditis (IE). The thermal effect was applied as a means
of achieving a bactericidal effect in the treatment of IE.
Temperatures between 72 and 75 ℃ destroy pathogenic
organisms including bacteria and viruses. This is a new
principle for achieving a “sterile” surface of infected areas.
This technique and principle have been successfully used
in 15 cases. The overall follow up of the authors’ series
is limited, and extent of invasive disease beyond the valve
leaflet not described (2). The results are impressive if they
hold up over time.
However, the report includes a detailed description
of one case of invasive aortic valve endocarditis, the
management raises several questions: “Two large annular
abscess orifices were identified, one beneath the left coronary artery
orifice and the other beneath the right coronary artery orifice.
Curettage was performed on the margin the abscess orifices, but
in order to prevent coronary artery injury and prevent complete
aorto- left ventricular dehiscence we were careful not to perform
excessive debridement, and thus, fragile inflammatory tissue
around the orifices remained. Infrared ablation was applied until
the fragile tissue became dry and discolored. After ablating the
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entire margins of the orifices, both abscess cavities were filled with
biological glue containing the antibiotic Amikacin, and the orifices
patched with xenopericardium.”
This case description violates basic principles described
in the recent AATS guidelines of surgical treatment of
endocarditis (3): it is a fundamental surgical principle to remove
infected material, foreign bodies, and necrotic tissue to minimize
the residual infectious burden and provide optimal access for hostdefense and antimicrobial therapy by surrounding the area with
healthy well-vascularized tissue. Infected areas must be opened and
unroofed and all infected pockets cleaned out. Instead the authors
cauterize the surface of the infected areas with the infrared
coagulator and fill the abscess cavities with a fibrinogen/
factor XIII sealant including an antibiotic. The AATS
guidelines say: “Debridement is followed by generous irrigation.
Many surgeons use local antiseptics and antimicrobials, but no
studies specific to IE support the value of this practice.” Many
surgeons still use local antibiotics to reduce the number of
live residual bacterial but coagulation of the surface tissue is
new. The authors also claim that the coagulation results in
firmer tissue to sew to. We are skeptical but not completely
dismissive of the principles introduced by the authors but
the report raises many questions which require translational
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research related to the validity of these principles:
Is it better to coagulate than to remove all infected and
necrotic tissue?—we are not convinced! If the coagulated
tissue is dead, it would become a substrate for any residual
bacteria. In burn injuries to skin and superficial muscle
there is often an abscess layered between dead and live
tissues. This is likely to happen also in the heart.
Is it true that coagulation improves quality of edematous
fragile tissue and allows such tissue to hold sutures
better?—over time the necrotic tissue will disintegrate. We
have demonstrated excellent results in patients who have
prosthetic valve endocarditis with thorough debridement
of all infected foreign material and necrotic tissue and
replacement of the aortic root with an allograft (4) and
many others have demonstrated similar results with other
conduits. Using allograft to reconstruct the root, additional
materials are almost never required, and if needed
autologous pericardium is our preference.
Sterilizing infected cavities, which cannot be left
open and communicating with the blood stream or the
pericardium remains an interesting principle and more so
for patients with invasive mitral valve and invasion to the
atrioventricular grove, than for patients with aortic valve
endocarditis.
The authors also need to specify the amount and
concentration of amikacin that they use and what the release
characteristics are.
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